A short story by the Weizmann Institute of Science's Peter Tsvetkov and Tel-Aviv University's Sharon Dekel posted at LabLit this week details a personified p53's visit with a "gene therapist." The transcription factor, it seems, is at odds with his roles in cancer and apoptosis. "When I was first discovered they accused me of being oncogenic, accused me of supporting cancer. It took them many years to understand that I am the good guy, that I'm a tumor suppressor.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.